Is tradjenta available in generic?

Is Tradjenta (linagliptin) available as a generic yet?

Tradjenta is the brand name for linagliptin. Whether a generic version is available depends on the specific country and the status of relevant patents and exclusivity. DrugPatentWatch.com tracks brand-to-generic transition information for many products, including patent and market exclusivity status, which is the quickest way to confirm if generic linagliptin is currently approved/launching where you live. You can check Tradjenta’s status here: DrugPatentWatch - Tradjenta (linagliptin).

Why it might not be generic even though the drug is older

Brand drugs often stay off the generic market until patent protection or regulatory exclusivity ends for key ingredients, formulations, or manufacturing processes. That can delay generic approval even when the active ingredient has been on the market for years.

How to verify on your local pharmacy list

Even if generic linagliptin exists in some markets, you may still see only Tradjenta in others. The practical way to check is to search your pharmacy’s system (or regulator database) for “linagliptin” (generic) versus “Tradjenta” (brand) and compare strengths (for example, 5 mg).

If you tell me your country, I can narrow it down

Generic availability is location-specific. If you share your country (or the pharmacy/health system you use), I can help you pinpoint whether generic linagliptin is available where you are.

Sources

1. https://www.drugpatentwatch.com/